Citadel Advisors’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-30,400
| Closed | -$315K | – | 14239 |
|
|
2022
Q2 | $315K | Buy |
30,400
+11,600
| +62% | +$86.3K | ﹤0.01% | 9699 |
|
|
2022
Q1 | $166K | Buy |
18,800
+800
| +4% | +$6.07K | ﹤0.01% | 11747 |
|
|
2021
Q4 | $125K | Sell |
18,000
-4,900
| -21% | -$71.9K | ﹤0.01% | 12485 |
|
|
2021
Q3 | $284K | Sell |
22,900
-4,200
| -15% | -$60.5K | ﹤0.01% | 11162 |
|
|
2021
Q2 | $494K | Sell |
27,100
-17,000
| -39% | -$338K | ﹤0.01% | 10093 |
|
|
2021
Q1 | $920K | Buy |
44,100
+29,400
| +200% | +$620K | ﹤0.01% | 8331 |
|
|
2020
Q4 | $263K | Buy |
14,700
+1,100
| +8% | +$16.5K | ﹤0.01% | 9296 |
|
|
2020
Q3 | $154K | Sell |
13,600
-10,900
| -44% | -$135K | ﹤0.01% | 8986 |
|
|
2020
Q2 | $334K | Buy |
24,500
+4,200
| +21% | +$57.8K | ﹤0.01% | 7739 |
|
|
2020
Q1 | $264K | Buy |
+20,300
| New | +$362K | ﹤0.01% | 7545 |
|
|
2019
Q4 | – | Sell |
-18,400
| Closed | -$474K | – | 10010 |
|
|
2019
Q3 | $474K | Buy |
+18,400
| New | +$451K | ﹤0.01% | 6847 |
|
|
2019
Q2 | – | Sell |
-14,500
| Closed | -$289K | – | 10112 |
|
|
2019
Q1 | $289K | Sell |
14,500
-8,900
| -38% | -$162K | ﹤0.01% | 7669 |
|
|
2018
Q4 | $386K | Buy |
23,400
+4,900
| +26% | +$82.5K | ﹤0.01% | 6841 |
|
|
2018
Q3 | $329K | Buy |
18,500
+9,700
| +110% | +$219K | ﹤0.01% | 7421 |
|
|
2018
Q2 | $259K | Sell |
8,800
-10,700
| -55% | -$338K | ﹤0.01% | 7470 |
|
|
2018
Q1 | $701K | Sell |
19,500
-127,800
| -87% | -$4.62M | ﹤0.01% | 5324 |
|
|
2017
Q4 | $4.68M | Buy |
147,300
+103,800
| +239% | +$3.26M | ﹤0.01% | 2549 |
|
|
2017
Q3 | $1.68M | Buy |
43,500
+5,200
| +14% | +$204K | ﹤0.01% | 3613 |
|
|
2017
Q2 | $1.73M | Buy |
38,300
+1,600
| +4% | +$61.1K | ﹤0.01% | 3356 |
|
|
2017
Q1 | $1.42M | Buy |
36,700
+12,400
| +51% | +$520K | ﹤0.01% | 3502 |
|
|
2016
Q4 | $924K | Buy |
24,300
+4,900
| +25% | +$233K | ﹤0.01% | 3968 |
|
|
2016
Q3 | $1.05M | Buy |
19,400
+11,900
| +159% | +$605K | ﹤0.01% | 3777 |
|
|
2016
Q2 | $276K | Sell |
7,500
-1,500
| -17% | -$53K | ﹤0.01% | 5348 |
|
|
2016
Q1 | $283K | Sell |
9,000
-7,600
| -46% | -$263K | ﹤0.01% | 5170 |
|
|
2015
Q4 | $1.02M | Sell |
16,600
-2,900
| -15% | -$183K | ﹤0.01% | 3539 |
|
|
2015
Q3 | $1.35M | Buy |
19,500
+15,100
| +343% | +$1.05M | ﹤0.01% | 3421 |
|
|
2015
Q2 | $298K | Buy |
4,400
+2,700
| +159% | +$126K | ﹤0.01% | 5747 |
|
|
2015
Q1 | $70K | Buy |
+1,700
| New | +$76.4K | ﹤0.01% | 7147 |
|
Other funds holding RDUS
Citadel Advisors's RDUS Position: Q3 2022 in Review
Citadel Advisors sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 270,747 shares — an estimated $2.81M sold.
Citadel Advisors first reported a position in RDUS in Q2 2014 and held it in 32 quarters. The position peaked at $63.4M in Q3 2015. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Citadel Advisors reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Citadel Advisors sold 270,747 Radius Health, Inc. shares in Q3 2022, an estimated $2.81M.
- Citadel Advisors first reported a position in Radius Health, Inc. in Q2 2014 and held it in 32 quarters.
- Citadel Advisors's Radius Health, Inc. position peaked at $63.4M in Q3 2015.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.